Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Onconova Therapeutics, Inc. (ONTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   8-K10-K10-K10-K10-K10-K10-K10-K
Revenue  0.20.20.22.21.20.85.511.5
            Revenue growth  0.0%-2.2%-89.4%77.8%56.0%-85.8%-51.6%1332.0%
Operating expenses:          
General and administrative  8.49.48.38.37.67.49.29.5
Research and development  11.47.316.915.516.919.120.125.9
    Total operating expenses  19.916.725.223.924.526.529.235.4
    Loss from operations  -19.6-16.5-25.0-21.7-23.3-25.7-23.7-24.0
            Operating margin  -8684.5%-7299.1%-10819.5%-994.0%-1895.9%-3270.3%-427.4%-209.3%
Other income, net  0.70.00.00.11.20.00.10.0
    Net loss   -16.2-25.2-21.5-20.4-24.1-19.7-24.0
   
Net loss per share, basic (in dollars per share)  ($0.91)($0.96)($2.17)($1.49)($4.99)($40.15)($4.44)($10.54)
Net loss per share, diluted (in dollars per share)  ($0.91)($0.96)($2.17)($1.49)($4.99)($40.15)($4.44)($10.54)
   
Basic weighted average shares outstanding (in shares)  20.916.811.614.44.10.64.42.3
Diluted weighted average shares outstanding (in shares)  20.916.811.6     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy